Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

Bipartisan deal on Obamacare subsidies fades as Republicans push HSA plan

admin by admin
December 3, 2025
in News
0
Bipartisan deal on Obamacare subsidies fades as Republicans push HSA plan
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

The chances of a bipartisan solution to expiring Obamacare subsidies are growing slimmer with each passing day as the Senate gears up for a vote next week on extending the credits.

Senate Democrats made the subsidies the focal point of their position during the government shutdown, which ended only after a group of Democrats broke from Senate Minority Leader Chuck Schumer, D-N.Y., based largely on a guarantee from Senate Majority Leader John Thune, R-S.D., that lawmakers would get a chance to vote on extending the subsidies.

And next week is Thune’s deadline to get a proposal on the floor, but the likelihood that it is bipartisan is fast fading.

‘I mean, my assumption is that by next week, when we have to have that vote, that we might not be far enough along in the bipartisan discussions. But my assumption is we’ll still have a vote of some kind, because that’s what we’re committed to do,’ Thune said.

Bipartisan talks have been ongoing, both during the shutdown and in the weeks after. But those have yet to yield a plan that could muster the 60 votes necessary to break through the filibuster in the upper chamber.

Republicans want to see reforms to the program and are floating proposals that would see money from the subsidies that normally flows to insurance companies be sent directly to Health Savings Accounts (HSAs) — a plan previously floated by President Donald Trump.

Democrats, however, want a cleaner extension of subsidies but are open to reforms either up front or down the line.

Sen. Roger Marshall, R-Kan., told Fox News Digital he’s been involved in talks with colleagues across the aisle, but those discussions had recently slowed. He agreed that a bipartisan solution was likely out of reach by next week’s vote.

‘I mean, I would love to see that, but it’s not realistic, and I’m putting my eggs into the basket for Jan. 30, a nice bipartisan package,’ he said.

At that point, however, the subsidies will have expired.

That leaves the option of a possible side-by-side vote, with Democratic and Republican proposals put on the floor to see which survives. But that idea may not have much support, either.

‘I don’t know about whether they would have the appetite for a side-by-side,’ Sen. Tammy Baldwin, D-Wis., said. ‘We certainly have not seen Republicans come up with any sincere plans to help alleviate the concerns.’

Senate Health, Education, Labor and Pensions Chair Bill Cassidy, R-La., who is leading Republicans’ negotiations for a plan on the subsidies, scoffed that if Democrats spoke with him, ‘You’re going to be hearing a lot of sincerity.’

Cassidy’s plan revolves around HSAs, which he sketched out in broad terms to Fox News Digital. Under his plan, HSAs would be pre-funded with, ‘say $2,000,’ that he argued would see Americans pay roughly the same health insurance deductibles and act as a much more workable day-to-day policy moving forward.

He noted that Democrats see where he’s coming from, but that he couldn’t say if he’s got ‘their vote yet.’

‘If you look at the numbers, there are people who are in their 50s and 60s who will really, like, pay a third of their income for insurance on the exchange, and so the Democrats have set it up so there’s a cliff at the end of this year, and we’re trying to avoid that cliff,’ Cassidy said.

‘So [we’re] looking for a way that can take care of those folks but begin to transition to a system which is much more workable,’ he continued. ‘The Obamacare subsidy system is not workable.’

Cassidy and Senate Finance Committee Chair Mike Crapo, R-Idaho, pitched ideas and options during the Senate GOP’s closed-door lunch on Tuesday, but there still wasn’t a solid consensus on a path forward on a Republican proposal.

Sen. John Kennedy, R-La., said it would take ‘divine intervention’ for Republicans to agree on a plan to vote on by Thune’s deadline next week.

‘Have you ever heard of a Rorschach test where it’s smeared all over the wall? That’s kind of where we’re at,’ Kennedy said.

Members on both sides of the aisle believe that Trump should get more involved, too, given that anything that passes the Senate and works through the House would need his signature to become law.

Sen. Angus King, I-Maine, one of the eight Democratic caucus members that voted to reopen the government with Republicans, said that it would help if Trump told the Senate GOP to make a deal.

‘I think the easiest, clearest thing would be a straight extension with some modest reforms, and then we can move on,’ King said. ‘And frankly, if it doesn’t happen, then the Republicans can own massive premium increases. And I don’t know why they would want to do that.’

This post appeared first on FOX NEWS

Previous Post

Court says Boasberg didn’t know Arctic Frost subpoenas hit lawmakers, Grassley calls that ‘deeply troubling’

Next Post

MIKE DAVIS: Why SCOTUS must reinstate Trump US Attorneys Alina Haba and Lindsey Halligan

Next Post
MIKE DAVIS: Why SCOTUS must reinstate Trump US Attorneys Alina Haba and Lindsey Halligan

MIKE DAVIS: Why SCOTUS must reinstate Trump US Attorneys Alina Haba and Lindsey Halligan

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

December 24, 2025
GLP-1 weight-loss pills set to reshape US food demand in 2026

GLP-1 weight-loss pills set to reshape US food demand in 2026

December 24, 2025
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

December 24, 2025
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

December 24, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    December 24, 2025
    GLP-1 weight-loss pills set to reshape US food demand in 2026

    GLP-1 weight-loss pills set to reshape US food demand in 2026

    December 24, 2025
    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    December 24, 2025
    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    December 24, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved